Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000084

President & CEO gave up 3,329 shares (to pay taxes)

  • President & CEO acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hirsch Andrew · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-16 Exercise or conversion : show line 1 in the form +7,500 218,241 D
2024-09-16 Shares withheld for taxes : show line 2 in the form −3,329 $6.36 $21,172 214,912 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-16 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −7,500 47,500 D
Loading xslF345X05/wk-form4_1726607560.xml…